SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is the project about? Vara Network is a substrate-based future proof smart contract platform that is fast, scalable, and makes it simple to create and deploy next-generation Web3.0 dApps Vara is the first standalone network in the Gear Protocol  Gear is a next-gen cloud infrastructure platform providing most intuitive and frictionless environment for web2 and web3 developers to build complex infrastructure solutions and disruptive dApps for any ecosystem  What makes your project unique? Vara is built upon three core concepts: The actor model, and persistent memory — two widely adopted primitives from massive computation and microservices architecture spaces  Wasm — a WebAssembly-based virtual machine that runs on all modern browsers. Proven to be faster than any alternative web2 virtual machines  Vara was created to serve as a wasm-native hub for innovative protocols that leverage parallel execution and asynchronous programming to deliver leading decentralized products in any segment  History of your project. Gear Protocol and the Vara Network were originally created by Nikolay Volf, one of the core developers of Polkadot. In 2021, he embarked on building an advanced layer 1 smart contract platform using Substrate, Polkadot's custom framework. His vision included creating a platform that enables fast and efficient execution of robust, feature-rich dApps while in a seamless development environment similar to that of Web 2.0 development. He did this by  harnessing the power of innovative technologies like Wasm, the Actor Model, and Persistent Memory. These technologies significantly enhance smart contract development and provide a seamless end-user experience and provide the foundation for the development of Vara Network.  1. Q2 2021 - Pre-Seed Round: In the second quarter of 2021, the Protocol secured its initial funding through a pre-seed round. This likely involved seeking investment from early-stage investors or venture capitalists to kickstart the development of the project.  2. Q4 2021 - Seed Round: In December 2021 raised $12 Million in Venture Round. Private investment round led by Blockchange Venture. In addition to Blockchange, other top venture capital funds participated in this round, including Three  Arrows Capital, Lemniscap, Distributed Global, LAO, Mechanism Capital, Bitscale, Spartan Group LLC, HashKey, DI Ventures, Elysium Venture Capital, Signum Capital and P2P Economy lead by Konstantin Lomashuk, along with a number of top executives of Web3 Foundation and Parity Technologies. Dr. Gavin Wood, Founder and ex-CEO of Parity Technologies and one of the key individual investors participating in this round.  3. 2022 - Intensive Scaling and Development, First Test Integrations: Throughout the year 2022, Vara was focused on two primary activities. First, the engagement in an extensive outreach process to build up the team. Second, the project advanced its technical development efforts and started working on integrating their technology with various test environments to ensure its functionality and viability.  4. Q4 2022 - Testnet Launch.   5. Q1 2023 - PoA Launch: In the first quarter of 2023, Vara achieved launch of its Proof of Authority (PoA) consensus network, which is a chain candidate for mainnet.  Current Status of Vara:  Presently, the project boasts a talented and diverse decentralized workforce, consisting of dozens of engineers and other community members  to drive the project's success.  One of the remarkable aspects of Vara is its substantial pipeline of initiatives with over 40 projects.  What’s next for your project? Current projects being researched and developed by the community:  - Intensive testing and improvement of the actor model features in the blockchain space  - Launch of the key stack of dApps in our parallel and asynchronous environment   - Development of innovative infrastructure solutions (e.g offchain zk actors including machine learning) independently and together with the segment leaders  What can your token be used for? VARA tokens maintain core utility features required for the network to operate: transaction fees staking and network security governance other: gas pools for gas reservation  Contributors to the Gear protocol are exploring the mechanics of how to distribute a portion of block rewards directly toward dApp developers

Vara Network

Vara Network is gaining trending momentum on Coinbase as investors weigh its potential as decentralized infrastructure and its recent integration into DeFi ecosystems against ongoing concerns regarding token dilution and supply unlocks. The community is actively debating the project's institutional partnerships and Real World Asset (RWA) utility while closely tracking staking rewards and price volatility for signs of a long-term breakout.

This first memecoin ever created completely by AI.

Turbo Toad Token

Turbo Toad Token is seeing significant community engagement as investors watch for a technical breakout, with many enthusiasts betting on its potential for a major rally alongside the broader altcoin market and AI-driven narrative. Participants are actively sharing bullish chart patterns, discussing long-term targets, and debating the token's ability to maintain momentum and reach previous highs as trading volume spikes.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is gaining momentum as a critical infrastructure provider in the DeFi space, fueled by its role in bringing institutional-grade data and U.S. government macroeconomic indicators onto the blockchain. The community is focused on the project's real-world utility, its revenue-sharing model through token buybacks, and its growing importance within the Real World Asset sector.

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

Constellation Energy Corp

Constellation Energy is experiencing significant volatility driven by the U.S. government's approval of a $1 billion federal loan to restart the Three Mile Island nuclear facility, a move designed to secure baseload power for Microsoft's AI data centers. While the community is actively debating the company's long-term valuation and the sustainability of the AI-nuclear trade, many traders are treating the recent price fluctuations as a tactical buying opportunity given the firm's critical role in the accelerating clean energy transition.

Canadian Natural Resources Ltd. is an oil and natural gas production company, which engages in the exploration, development, marketing, and production of crude oil and natural gas. It operates through the following segments: Oil Sands Mining & Upgrading, Midstream & Refining, and Exploration & Production. The Oil Sands Mining & Upgrading segment produces synthetic crude oil through bitumen mining and upgrading operations. The Midstream & Refining segment focuses on maintaining pipeline operations and investment. The Exploration & Production segment consists of operations in North America, largely in Western Canada, the United Kingdom portion of the North Sea, and Côte d’Ivoire and South Africa in Africa. The company was founded on November 7, 1973 and is headquartered in Calgary, Canada.

Canadian Natural Resources Ltd.

Canadian Natural Resources Ltd. (CNQ) is trending as investors favor its strong production capacity and disciplined capital allocation, particularly amidst discussions about the company's role in filling global heavy oil supply gaps. The community is actively debating the stock's valuation, dividend reliability, and potential for further growth as shareholders watch for production momentum to offset commodity price fluctuations.

EOG Resources, Inc. engages in the exploration, development, production and marketing of crude oil and natural gas. It operates through the United States, Trinidad, and Other International geographical segments. The Other International segment includes China and Canada operations. The company was founded in 1985 and is headquartered in Houston, TX.

EOG Resources, Inc.

EOG Resources is trending as investors weigh strong production results and recent strategic acquisitions in the Utica shale against broader energy sector volatility. The community is actively discussing its potential as a core dividend-paying energy leader while monitoring institutional flow and technical support levels amid shifting global oil supply dynamics.

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Clene Inc

Clene Inc. is trending as investors await critical updates following a recent Type C meeting with the FDA, with community sentiment heavily focused on potential accelerated approval for its ALS treatment, CNM-Au8. Discussion is driven by intense speculation regarding upcoming biomarker analysis results and whether the company will secure an NDA filing by the end of the year.

Canton Coin (CC), the network’s native utility token, was designed to reward real network usage over speculation. It aligns the success of the network with the participants who make it work, fairly rewarding app builders and app users, as well as those operating decentralized infrastructure. The result is a fundamentally different model where rewards flow to those creating value through real activity, not only miners or early investors.

Canton

Canton (CC) is trending as community members rally around its growing institutional partnerships and recent exchange listings, fueling bullish sentiment despite broader market volatility. Investors are actively discussing the project's real-world utility in tokenization and its potential for long-term growth as a key infrastructure layer.

EyePoint Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals is seeing heightened investor attention as market analysts maintain bullish sentiment and high price targets ahead of upcoming Phase 3 trial milestones for its lead asset, Duravyu. The community is actively debating the company's competitive standing against Ocular Therapeutix, while closely monitoring institutional buying activity and the impact of ongoing regulatory and legal risk factors.

Sony Group Corp. engages in the development, design, manufacture, and sale of electronic equipment, instruments, devices, game consoles, and software for consumers, professionals and industrial markets. It operates through the following segments: Game and Network Services, Music, Pictures, Home Entertainment and Sound, Imaging Products and Solutions, Mobile Communications, Semiconductors, Financial Services, and Others. The Game and Network Services segment deals with gaming machines, software and network services. The Music segment produces and publishes music and provides image media platforms. The Pictures segment handles film production, television program creation, and media networks. The Home Entertainment and Sound segment offers LCD televisions, home audio, Blu-ray Disc players and recorders, and memory-based portable audio devices. The Imaging Products and Solutions segment provides digital imaging products, professional solutions, and medical goods. The Mobile Communications segment deals with mobile phones and Internet services business. The Semiconductors segment provides image sensors and camera modules. The Financial Services segment manages the life insurance and non-life insurance operations and banking business. The Others segment includes personal computer (PC) business, overseas Blu-ray Disc, DVD and CD manufacturing, and battery business. The company was founded by Akio Morita and Masaru Ibuka on May 7, 1946 and is headquartered in Tokyo, Japan.

Sony Group Corporation - ADR

Sony Group Corporation

Sony is experiencing significant momentum driven by a strong product pipeline, positive analyst sentiment, and anticipation surrounding high-profile releases like GTA VI and upcoming PS5 hardware updates. Community sentiment remains largely bullish, with investors actively discussing the company's long-term growth prospects, potential spinoffs of its financial and semiconductor divisions, and its strategic synergy between entertainment and hardware sectors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What's Going On With Shares Of SeaStar Medical Today?

Shares of SeaStar Medical Holding Corporation (NASDAQ: ICU) are trading lower Friday after the company initiated a reverse stock split.read more...

A Glimpse of SeaStar Medical Holding's Earnings Potential

SeaStar Medical Holding Corp. shares rose 7% to their highest level in more than three months on Wednesday after the company said an independent safety board had reviewed early data and recommended continuing its pivotal trial of a kidney failure therapy.However, the stock&nbsp;crashed 46% in after-hours trading on Wednesday.The Data Safety Monitoring Board (DSMB) conducted an interim review of the first 100 patients in the Neutralize-AKI study of the company’s Selective Cytopheretic Device (SCD) in adults with acute kidney injury requiring continuous renal replacement therapy.&nbsp;The panel found no device-related safety concerns and reported zero adverse events tied to the treatment. It also flagged a signal of potential clinical benefit across key measures.To boost the statistical power of the trial, the DSMB recommended increasing enrollment from 200 to 339 patients. SeaStar said 137 patients have already been enrolled and expects to complete recruitment near the end of 2026. The company plans to accelerate enrollment by adding new trial sites.The Neutralize-AKI trial will measure a composite of 90-day mortality or dialysis dependency, with additional endpoints including 28-day mortality, ICU-free days, and dialysis dependency at one year. Subgroup analyses will evaluate patients with sepsis and acute respiratory distress syndrome.SeaStar’s SCD therapy, marketed as Quelimmune, is already approved by the FDA for life-threatening acute kidney injury in children with sepsis or septic conditions. Early real-world registry data showed no safety concerns and a 75% survival rate at 28 days, suggesting a possible reduction in mortality compared with historical outcomes.On Stocktwits, retail sentiment was ‘extremely bullish’ amid ‘extremely high’ message volume.One user suggested that warrant holders had timed the news to capitalize on the stock’s spike, noting they could profit as long as shares remained above their average price and questioning whether the market could absorb the additional supply.<stembedurl>https://stocktwits.com/alphaonetrading/message/629922155</stembedurl>Another user said the recent price surge was only the beginning, arguing that strong safety signals from the trial support future runs and calling any near-term pullback a buying opportunity for the long term.<stembedurl>https://stocktwits.com/MasheredTrader/message/629918153</stembedurl><a href="https://stocktwits.com/symbol/ICU">SeaStar Medical’s stock</a> has declined 36.1% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Chronic kidney disease, computer illustration and light micrograph. The illustration shows the gross anatomy of kidneys with chronic glomerulonephritis. | Image source: Getty Images

SeaStar Medical Stock Jumps On Safety Board Backing For Kidney Trial; Retail Eyes Another Run Despite After-Hours Plunge

SeaStar’s SCD therapy, marketed as Quelimmune, is already approved by the FDA for life-threatening acute kidney injury in children with sepsis or septic conditions.

Equity

The trial’s enrollment target has been raised to 339 patients, with completion expected by late 2026.

Shares of SeaStar Medical Holding Corporation (ICU) slumped 61% on Friday afternoon after the healthcare company <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.seastarmedical.com/news/news-details/2025/SeaStar-Medical-Announces-Pricing-of-Up-to-8-Million-Public-Offering/default.aspx">announced</a> the pricing of a public offering of over six million shares of its common stock at $0.65.The offer price of $0.65 represents a 33% discount on the stock’s closing price on Wednesday.The gross proceeds to the company from the offering are expected to be approximately $4 million, before deducting the placement agent’s fees and other offering expenses payable. SeaStar said it intends to use the net proceeds from the offering for general corporate purposes. The offering is expected to close on or about June 23, 2025.SeaStar Medical is a commercial-stage healthcare company focused on treatments for critically ill patients facing organ failure and potential loss of life.Its Quelimmune product was approved by the U.S. Food and Drug Administration (FDA) last year for the ultra-rare condition of life-threatening acute kidney injury (AKI) due to sepsis or a septic condition in critically ill pediatric patients.On Stocktwits, retail sentiment around SeaStar rose from ‘neutral’ to ‘bullish’ over the past 24 hours while message volume remained ‘high’.<figure class="image"><img style="aspect-ratio:622/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_20_at_1_11_54_PM_png_87eaa0be26.webp" alt="ICU's Sentiment Meter and Message Volume as of 1:10 p.m. ET on June 20, 2025 | Source: Stocktwits" width="622" height="64"><figcaption>ICU's Sentiment Meter and Message Volume as of 1:10 p.m. ET on June 20, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expressed dissatisfaction with the lack of clarity around the management’s decisions.<stembedurl>https://stocktwits.com/Saxon_stock/message/618487152</stembedurl>Another opined that the company is inching close to bankruptcy.<stembedurl>https://stocktwits.com/Cowsheeptheone/message/618483251</stembedurl><a href="https://stocktwits.com/symbol/ICU">ICU stock</a> is down by 81% this year and by over 93% in the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/amazon-ends-kia-soul-same-day-delivery-program/chlxYXvRRPx">Amazon Ends Same-Day Deliveries Via Kia Souls, Leans On Its Network Of Gig Workers: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

SeaStar Medical Stock Tanks At Discounted Pricing Of Public Offering, Retail Believes Company Is Inching Closer To Bankruptcy

The public offer price of $0.65 represents a 33% discount on the stock’s closing price on Wednesday.

Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company was founded on June 6, 2007 and is headquartered in Denver, CO.

ICU
SeaStar Medical Holding Corp

Feed

News

Sentiment

Fundamentals

Info

Latest ICU News

ICUSeaStar Medical Holding Corp